Written by Jianping Liu, Xun Li and the CAM-Cancer Consortium.
Updated July 30, 2009

Chinese herbal medicine for advanced pancreatic cancer

What is Chinese herbal medicine for advanced pancreatic cancer?

TCM is a 3,000-year-old holistic system of medicine combining medicinal herbs, acupuncture, food therapy, massage, and therapeutic exercise for both treatment and prevention of diseases 1. It has its unique theories around concepts of aetiology, systems of diagnosis, and treatment, which are vital to its practice. The theories of TCM include Yin-Yang (e.g. positive and negative), the five elements (fire, earth, metal, water, and wood), Qi (vital energy) and blood, Zhang-Fu (five viscerae and six bowels), as well as channels and collaterals (Meridian doctrine) 2 3. Diseases are considered to result from internal causes as well as external causes, which are defined as disturbances e.g., the imbalance between Yin and Yang. Chinese medicines consist typically of complex prescriptions combining between four and 12 different herbal ingredients, including minerals or animal components. The combinations are based on special Chinese diagnostic patterns that involve inspection, listening, smelling, inquiry, and palpation. Herbs are used for correcting the imbalance of Yin and Yang in the body and maintaining kinetic balance under the movement of five elements. “Bianzheng Lunzhi” (the differentiation of symptom patterns and the prescription of formula of herbs) is the application of these theories.

Herbal therapy is the most commonly used part of TCM, and includes around 3,200 herbs. Herbs often used in cancer patients include Ginkgo biloba, Panax ginseng, Astragalus membranaceus. About 300 mineral and animal extracts and over 400 formulas are used 2. TCM herbal therapy is applied in three different ways, including individualised treatment (prescription of herbs on the basis of a TCM differentiation of the symptoms), use of fixed herbal formula (such as Chinese patented medicines), or the combined use of herbal medicine with conventional therapy. The composition of herbal preparations, dosage, and treatment duration vary.

Prevalence of use

Traditional Chinese herbal medicine has been used in China to manage the symptoms of patients with pancreatic cancer, such as jaundice, pain, and low appetite. There is no available data for the prevalence of herbal medicine use in pancreatic cancer patients. However, in China, it is not uncommon for patients with advanced pancreatic cancer to use herbal preparations and other TCM therapies.

Theory

In TCM, there is no equivalent diagnosis for pancreatic cancer, but the treatment intends to relieve the symptoms related to pancreatic cancer. Herbal treatment is designed to inhibit tumour growth and metastasis, stop pain and improve symptoms, reduce the adverse effects of chemotherapy and/or radiotherapy, enhance immunity, prevent relapse, increase survival, and improve quality of life.

According to TCM theory, practitioners prescribe herbal formulae according to the differentiation of symptoms of patients with pancreatic cancer 4. Therefore, the treatment varies from patient to patient and even at different stages of the disease.

Providers

TCM practitioners can either prescribe herbal formulae as decoctions, or prescribe commercially marketed herbal products such as Chinese patented medicines. Chinese patented medicines are manufactured mainly in China, while other neighbouring countries such as Japan, Korea, also produce herbal products.

Legal issues

In most European countries, herbal medicines are strictly regulated as dietary supplements. The European Directive on Traditional Herbal Medicinal Products allows herbal medicines to be registered as drugs if they have been used for 30 years (at least 15 years in EU countries and 15 years in non-EU countries). 5

Citation Jianping Liu, Xun Li, CAM-Cancer Consortium. Chinese herbal medicine for pancreatic cancer [online document]. http://www.cam-cancer.org/CAM-Summaries/Alternative-Medical-Systems/Chinese-herbal-medicine-for-pancreatic-cancer. July 30, 2009.

References

  1. Fulder S. The handbook of alternative and complementary medicine. Oxford: Oxford University Press. 1996.
  2. Liu CC, Chen XJ, Fang XW. Essentials of Traditional Chinese Medicine. In: The English-Chinese Encyclopedia of Practical Traditional Chinese Medicine, edited by Xu XC. Beijing: Higher Education Press of China. 1991. Vol 1, p:1-4.
  3. Cheng JT. Review: Drug therapy in Chinese Traditional Medicine. J Clin Pharmacol 2000; 40:445-50.
  4. Kevin V. Ergil. Chinese Medicine in: Fundamentals of Complementary and Alternative Medicine. Edited by Micozzi, MS. Churchill Livingstone Inc. 1996 New York.
  5. http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-1/dir_2004_24/dir_2004_24_en.pdf, accessed 12 June 2009
  6. He YH, Lin HS. Clinical observation on 63 cases of pancreatic cancer at medium or advanced stage treated by integrated Chinese and western medicine. Chinese Journal of Information on Traditional Chinese Medicine 2001;8(3):65.
  7. Wang BS, Liu XF, Wu ZQ, Wang YQ, Fu XC, Zhao ZH, Ding RL, Li CY, Hu SJ. Effect of Qi replenishing and blood circulation activating drugs in treatment of middle-advanced pancreatic cancer with radio-and chemotherapy. Chinese Journal of Integrated Traditional Chinese and Western Medicine 2000;20(10):736-8.
  8. Yang XE, Liu T, Dong YH. Clinical observation of Yan Shu injection on the quality of life in pancreatic cancer patients with medium or advanced stage. Shanxi Journal of Traditional Chinese Medicine 2008;24(10):18-9.
  9. Li Q, Lei ZM, Zheng XM, et al. Clinical observation of Shenqi Yiai Ye and cytokine for treatment of advanced liver cancer and pancreatic cancer. Henan Journal of Oncology 1999;12(1):27-9.
  10. Jiang YH, Song TT, Lan XZ. Analysis of therapeutic effects in treating the local advanced pancreatic cancer patients by TCM plus chemotherapy. Chinese Journal of Cancer Prevention and Treatment 2006;13(24):1907-8.
  11. Shen YH, Liu LM, Chen Z, Meng ZQ, Song MZ, Yu EX. Study on Chinese medicine combined with chemotherapy for treatment of 32 cases of advanced pancreatic cancer. Journal of Traditional Chinese Medicine 2006;47(2):115-7.
  12. Yang BK. Clinical observation of 42 cases of pancreatic cancer treated by Chinese medicine. Zhejiang Journal of Traditional Chinese Medicine 1988;5(3):44.
  13. Liu HX, Liu XZ. Therapeutic observation of Chinese medicine for treatment of pancreatic cancer. Chinese Journal of Clinical Oncology and Rehabilitation 1996;(2):77-8.
  14. Wang QC, Zhang L, Li S. Treatment of 13 patients with advanced pancreatic cancer by Chinese medicine. Sichuan Journal of Chinese Medicine 1996;(10):20-1.
  15. You JL, Zhao JF. Tiaopi Yiyi formula for treatment of 42 cases of advanced pancreatic cancer. Zhejiang Journal of Chinese Medicine 2000;35(6):238.
  16. Wu YM, Shi SZ. Clinical observation of Jinlong capsule plus herbal medicine for treatment of 21 cases of pancreatic cancer at medium or late stage. Beijing Journal of Traditional Chinese Medicine 2002;21(6):349-51.
  17. Yang BK, Huo JG, Cao ZJ. Clinical observation of 68 case mid-late pancreatoblastoma treated by the traditional Chinese medicine. Chinese Journal of Basic Medicine in Traditional Chinese Medcine 2002;8(4):56-8.
  18. Sun YB, Zhou YN. Clinical observation on 22 cases of pancreatic cancer at medium and advanced stage treated by Hejie therapy combined with external use of Chinese herbal medicine. Chinese Journal of the Practical Chinese with Modern Medicine 2003;16(12):1770-1.
  19. Gu Y, Jin DZ, Yang JK. Clinical and experimental study of strengthening spleen traditional Chinese medicine WCA-P in treating pancreas cancer. Chinese Archives of Traditional Chinese Medicine 2005;23(11):2103-4.
  20. Lu JX, Yang BK. Differentiation of symptoms and treatment of 30 cases of medium and advanced pancreas cancer. Zhejiang Journal of Traditional Chinese Medicine 2000;35(4):150-1.
  21. Ni YQ, You JL, Yang ZX, Hu PP. Integrated Chinese medicine and conventional therapy for treatment of 21 cases of advanced pancreatic cancer. Liaoning Journal of Traditional Chinese Medicine 2005;32(12):1293.
  22. Ni YQ, Lin S. Xiao Zheng Gao for treatment of 24 cases of advanced pancreatic cancer with pain. Liaoning Journal of Traditional Chinese Medicine 2008;35(1):60-1.
  23. Xiao JX, Gao GJ. Report of 32 cases of pancreatic cancer treated by integrated Chinese and western medicine. Academic Journal of Suzhou University (Medicine version) 2002;22(2):233-4.
  24. Yang JZ. Experience introduction of Prof Qiu Jiaxin for treatment of pancreatic cancer with a analysis on therapeutic effect of 16 cases. Shanxi Journal of Traditional Chinese Medicine 2001;22(6):354-5.
  25. Lei YZ. Report of five cases of pancreatic cancer who survived for more than two years by Chinese medicine. Hubei Journal of Traditional Chinese Medicine 1980;2(1):51-2.
  26. Yang BK, Lu JX. Treatment experience of one case of pancreatic cancer. Shanghai Journal of Chinese Medicine 1995;(8):13.
  27. Han XZ. Therapeutic observation of one case of pancreatic cancer treated by integrated traditional and western medicine. Journal of Practical Chinese Internal Medicine 1990;(2):29.
  28. Li ZC, Hou P, Chen PJ, et al. Dual-cathetery of chemotherapy combined with Chinese medicine for treatment of 35 cases of pancreatic cancer. Academic Journal of Harbin Medical University 1997; 31(2): 153-5.
  29. He YH, Dong HT, Wang P, Pu BK, Sun GZ, Lin HS. Oral taking of Gexia Zhuyu Tang combined with transcathetery artery infusion for treatment of 26 cases of advanced pancreatic cancer. Chinese Journal of Integrated Traditional and Western Medicine in Surgery 2001;7(2): 81-2.
  30. Liu LM, Wu LC, Yang WH, et al. Clinical observation on 56 cases of advanced pancreatic cancer for treatment of pain with integrated Chinese and western medicine. Conference Proceeding of the Eighth National Conference of Integrative Chinese and Western Medicine for Cancer. May 2000:109. Qingdao, China.
  31. Kong ZZ, Huang T. Clinical observation of Tong Xue Kang for treatment of advanced pancreatic cancer with pain. Conference Proceeding of the Eighth National Conference of Integrative Chinese and Western Medicine for Cancer. May 2000:109-110. Qingdao, China.
  32. Schwarz RE, Donohue CA, Sadava D, Kane SE. Pancreatic cancer in vitro toxicity mediated by Chinese herbs SPES and PC-SPES: implications for monotherapy and combination treatment. Cancer Lett 2003;189(1):59-68.
  33. Vickers A, Goyal N, Harland R, Rees R. Do certain countries produce only positive results? A systematic review of controlled trials. Control Clin Trials. 1998;19(2):159-66.
  34. Melchart D, Linde K, Weidenhammer W, Hager S, Shaw D, Bayer R. Liver enzyme elevations in patients treated with traditional Chinese medicine. Journal of the American Medical Association 1999;282(1):28-9.
  35. Tomlinson B, Chan TY, Chan JC, Critchley JA, But PP. Toxicity of complementary therapies: an eastern perspective. Journal of Clinical Pharmacology 2000;40(5):451-6.
  36. Izzo AA. Herb-drug interactions: an overview of the clinical evidence. Fundam Clin Pharmacol 2005;19(1):1-16.
  37. Williamson EM. Interactions between herbal and conventional medicines. Expert Opin Drug Saf 2005;4(2):355-78.
  38. Mohammad RM, Al-Katib A, Aboukameel A, Doerge DR, Sarkar F, Kucuk O. Genistein sensitizes diffuse large cell lymphoma to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy. Mol Cancer Ther 2003; 2(12):1361-8.